Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

518 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

NCT01253161

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +12 more
Locations: Stanford Cancer Institute Stanford, California, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma

NCT02947607

Conditions: Carcinoma, Colonic Diseases, Colorectal Adenoma and Carcinoma, +12 more
Locations: Universitaire Ziekenhuizen Leuven Leuven, Flemish Brabant, Belgium

Academisch Medisch Centrum Amsterdam, Netherlands

View Trial Details

Completed

A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors

NCT03420742

Conditions: Carcinoma, Carcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors, Lung Diseases, +8 more
Locations: Hopital de la Timone Marseille, Provence-Alpes-Côte d'Azur Region, France

Groupe Hospitalier Bichat-Claude Bernard - Hopital Bichat Paris, Île-de-France Region, France

Centro di Riferimento Oncologico di Aviano Aviano, Pordenone, Italy

Policlinico Sant'Orsola Malpighi Bologna, Italy

View all 14 locations

View Trial Details

Completed

Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma

NCT05593744

Conditions: Carcinoma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: Qilu Hospital, Shandong University Jinan, Shandong, China

View Trial Details

Completed

Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer

NCT02898116

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations: Research Facility New York, United States

View Trial Details

Completed

Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer

NCT02440425

Conditions: Adnexal Diseases, Carcinoma, Disease Attributes, +20 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Duke University Durham, North Carolina, United States

VCU Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

NCT00446446

Conditions: Cancer, Carcinoma, Carcinoma, Squamous Cell, +17 more
Locations: Not specified

View Trial Details

Completed

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

NCT02072356

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +12 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT01592721

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

Cancer Therapy and Research Center at UTHSCSA San Antonio, Texas, United States

View Trial Details

Completed

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

NCT05495529

Conditions: Ablation Techniques, Carcinoma, Carcinoma, Hepatocellular (RENI), +16 more
Locations: CHU de Nice Nice, France

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions